Management of Growth Retardation in Juvenile Idiopathic Arthritis
- 1 December 2007
- journal article
- review article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 68 (Suppl. 5) , 122-125
Abstract
Background: Inflammation and glucocorticoid therapy are major factors in the growth retardation seen in children with severe forms of juvenile idiopathic arthritis (JIA). It has been recently shown that tumor necrosis factor (TNF)-α antagonist therapy can improve growth velocity in JIA patients; however, the recombinant human soluble TNF-α receptor fusion protein etanercept has had limited efficacy in systemic forms of JIA. For several years, growth hormone (GH) has been used to treat growth retardation in patients with JIA receiving glucocorticoids. GH treatment can normalize growth velocity and prevent the severe loss of height; however, catch-up growth markedly varies with the severity of the inflammatory state and the steroid doses used during GH treatment. Recently, early institution of GH treatment has been shown to maintain normal growth in children with JIA. Conclusions: These promising results show the need for careful monitoring of growth in children with JIA, the utility of GH therapy before the onset of severe growth delay and the potential for preservation of long-term growth during disease progression.Keywords
This publication has 6 references indexed in Scilit:
- Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritisAnnals of the Rheumatic Diseases, 2006
- Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled studyThe Journal of Pediatrics, 2003
- Treatment of Glucocorticoid-Induced Growth Suppression with Growth HormoneThe Journal of Clinical Endocrinology & Metabolism, 1998
- Beneficial Effects of One-Year Growth Hormone Administration to Children with Juvenile Chronic Arthritis on Chronic Steroid Therapy. I. Effects on Growth Velocity and Body CompositionThe Journal of Clinical Endocrinology & Metabolism, 1998
- Juvenile rheumatoid arthritis. Effects of disease activity and recombinant human growth hormone on insulin‐like growth factor 1, insulin‐like growth factor binding proteins 1 and 3, and osteocalcinArthritis & Rheumatism, 1997
- Growth in Still's DiseaseAnnals of the Rheumatic Diseases, 1956